First, the accumulation of the drug-loaded sEVs in skin lesions led to the accumulation of drugs at high concentrations in the psoriasis region, which likely contributed to the prominent therapeutic effects of the drug-loaded IFNγ-sEVs. This evidence concerns the gene IFNG and psoriasis.